ClinicalTrials.Veeva

Menu

The Optimal Oblique and Axial Angle of Fluoroscope for Superior Hypogastric Plexus Block

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Chronic Pelvic Pain
Pelvic Malignancy
Superior Hypogastric Plexus Block

Study type

Observational

Funder types

Other

Identifiers

NCT01604837
2012-03-074

Details and patient eligibility

About

The recommended entry angle for superior hypogastric plexus block is different among references, and there is a need for suggesting a more accurate entry angle for this procedure. The investigators are trying to evaluate the entry angle for superior hypogastric plexus block by measuring these angle on the computed tomography image and apply these angle to the real patients.

Full description

Superior hypogastric plexus block is a kind of sympathetic plexus block which are used to control the pelvic pain caused by malignancy or other chronic condition. Classic posterior approach for this procedure is inserting the block needle at L4 -5 level and proceed the needle 45 degrees medially and 30 degrees caudally to reach the target of anterolateral space of L5 - S1 intervertebral space. Waldman et al. introduced a different angle of 30 degrees medial and caudal with the same approach, while Stevens et al. recommended 15 degrees medial and 20 degrees caudal. As such, the recommended angle for this procedure is different among references, and there is a need for suggesting a more accurate entry angle for this procedure. Therefore, we are trying to evaluate the entry angle for superior hypogastric plexus block by measuring these angle on the computed tomography image and apply these angle to the real patients.

Enrollment

268 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Those undergoing abdominopelvic CT scan with pelvic malignancy or chronic pelvic pain with constitutional disease

Exclusion criteria

  • Poor CT image with non-measurable axial or oblique entry angle

Trial design

268 participants in 2 patient groups

Pelvic malignancy group
Description:
those with diagnosis of gynecologic or urologic malignancy
Pelvic chronic disease group
Description:
those with chronic pelvic pain with constitutional cause e.g. endometriosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems